Private Advisory Group’s GSK GSK Stock Holding History

Private Advisory Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-121,295	Closed	-$4.67M	–	207
2024 Q2	$4.67M	Buy	121,295 +11,457	+10%	+$482K	0.61%	46
2024 Q1	$4.71M	Buy	109,838 +63,068	+135%	+$2.6M	0.67%	45
2023 Q4	$1.73M	Buy	46,770 +791	+2%	+$28.4K	0.3%	79
2023 Q3	$1.67M	Buy	45,979 +10,004	+28%	+$355K	0.33%	77
2023 Q2	$1.28M	Sell	35,975 -139,256	-79%	-$5M	0.25%	91
2023 Q1	$6.23M	Sell	175,231 -35,973	-17%	-$1.26M	1.33%	23
2022 Q4	$7.42M	Sell	211,204 -10,118	-5%	-$337K	1.62%	18
2022 Q3	$6.51M	Buy	221,322 +128,059	+137%	+$4.85M	1.49%	17
2022 Q2	$5.08M	Buy	93,263 +2,887	+3%	+$159K	1.15%	30
2022 Q1	$4.92M	Buy	+90,376	New	+$4.91M	0.96%	29

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Private Advisory Group's GSK Position: Q3 2024 in Review

Private Advisory Group sold out of GSK (GSK) in Q3 2024, closing a stake of 121,295 shares — an estimated $4.67M sold.

Private Advisory Group first reported a position in GSK in Q1 2022 and held it in 10 quarters. The position peaked at $7.42M in Q4 2022. 900 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

Private Advisory Group reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
Private Advisory Group sold 121,295 GSK shares in Q3 2024, an estimated $4.67M.
Private Advisory Group first reported a position in GSK in Q1 2022 and held it in 10 quarters.
Private Advisory Group's GSK position peaked at $7.42M in Q4 2022.
900 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Private Advisory Group's 13F filing for Q3 2024, filed 9 Oct 2024.